Nephrology News

The FDA has granted fast-track designation to CABA-201, a CD19-CAR T cell investigational therapy, for the treatment of systemic lupus erythematous and lupus nephritis, according to a press release from the manufacturer.

In rheumatology, there is no shortage of conditions that are difficult to diagnose, with diseases like fibromyalgia and systemic lupus erythematosus sometimes taking years before being officially identified — leading to adverse outcomes.

Parathyroidectomy had no significant impact on long-term kidney function among older adults with primary hyperparathyroidism, but if done early, it could preserve function in those aged younger than 60, according to researchers.

Over time, a declining hemoglobin z score correlates with impaired height among children with mild to moderate nonglomerular chronic kidney disease, according to data published in the American Journal of Kidney Diseases.

The Health Resources Services Administration, which oversees the contract with the United Network for Organ Sharing to manage the U.S. organ procurement system, has launched a new initiative aimed at improving access to donor organs.

The incidence of kidney stone recurrence did not significantly differ among patients who received hydrochlorothiazide compared with those who received placebo, according to a study published in The New England Journal of Medicine.

Reduced kidney function was associated with increased levels of dementia-related blood biomarkers, but not an increased risk for Alzheimer’s disease or dementia, researchers reported in JAMA Network Open.

Testing for coronary heart disease within 12 months before kidney transplantation did not correlate with a change in death or myocardial infarction within 30 days after the transplant, according to data published in JAMA Internal Medicine.

Health care professionals around the world are reporting that the COVID-19 pandemic has prevented patients with systemic lupus erythematosus from receiving optimal care, resulting in increased risk for organ damage, according to a survey.

Increased fat mass, particularly visceral adiposity, promotes kidney disease generation and progression through direct and indirect mechanisms, and pharmacologic treatment is necessary to avoid adverse outcomes, according to a speaker.